Organogenesis Holdings Inc (ORGO) — Cash Flow Reinvestment Rate
Organogenesis Holdings Inc (ORGO) has a Cash Flow Reinvestment Rate of 1.45x as of September 2025, reinvesting $4.47 Million (capex $2.23 Million plus investments $-2.23 Million) from operating cash flow of $3.08 Million. Check ORGO cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Organogenesis Holdings Inc Cash Flow Reinvestment Rate (2020–2024)
Historical reinvestment intensity for Organogenesis Holdings Inc across 5 annual periods. Explore ORGO operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Organogenesis Holdings Inc (2020–2024)
Year-by-year capital reinvestment analysis for Organogenesis Holdings Inc. For live market cap and broader valuation context, see Organogenesis Holdings Inc stock valuation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.41x | $20.06 Million | $14.21 Million | $10.03 Million | ▼ -22.1% |
| 2023 | 1.81x | $56.06 Million | $30.92 Million | $24.36 Million | ▼ -33.5% |
| 2022 | 2.73x | $67.80 Million | $24.86 Million | $33.90 Million | ▲ +170.7% |
| 2021 | 1.01x | $62.44 Million | $61.98 Million | $31.22 Million | ▼ -87.0% |
| 2020 | 7.78x | $42.51 Million | $5.47 Million | $17.68 Million | — |